You are viewing the site in preview mode

Skip to main content

Table 1 Characteristics of patients

From: Relationship between bmi and glomerular filtration rate in a large cohort initiating a weight loss program: differential contributions of fat mass, fat-free mass, and abdominal fat compartments

 

Women

Men

Total

n = 7012

n = 2692

n = 9704

Median

P25

P75

Median

P25

P75

Median

P25

P75

Age (years)

47

37

55

47

38

56

47

37

55

BMI (kg/m2)

27.5

24.5

31.2

29.6

26.9

32.7

28.1

25.1

31.8

Body fat (%)

39

35.4

41.8

31.4

27.5

35.3

37.2

32.4

40.8

FMI (kg/m2)

10.7

8.8

13

9.3

7.6

11.3

10.3

8.4

12.5

FFMI (kg/m2)

16.8

15.6

18.4

20.2

18.9

21.8

17.7

16

19.9

Waist circumference (cm)

91.5

83.2

101

105.2

97.4

113

95.3

86

105

VAT (cm)

3.9

2.8

5.6

6.9

5

8.7

4.6

3.1

6.7

SAT (cm)

2.6

1.8

3.4

2.5

1.8

3.3

2.6

1.8

3.4

Glucose (mg/dl)

92

86

99

98

91

105

94

87

101

Triglycerides (mg/dl)

82

61

113

113

80

162

89

65

126

HDL (mg/dl)

64

55

75

48

41

56

59

49

71

Systolic blood pressure (mm Hg)

120

110

130

130

120

135

120

110

130

Diastolic blood pressure (mm Hg)

75

70

80

80

76

86

80

70

82

Creatinine (mg/dl)

0.7

0.6

0.8

0.9

0.8

1

0.8

0.7

0.9

GFR (ml/min/1.73 m2)

101.4

88.1

112

97.9

86.2

108

100.4

87.5

111

 

N

%

 

N

%

 

N

%

 

BMI classes

 Normal weight

2066

29.5

 

314

11.7

 

2380

24.5

 

 Overweight

2736

39

 

1125

41.8

 

3861

39.8

 

 Obesity

2210

31.5

 

1253

46.5

 

3463

35.7

 

High waist circumference ( 102 cm M/ 88 cm F)

4321

61.6

 

1627

60.4

 

5948

61.3

 

High triglycerides ( 150 mg/dl or treatment)

948

13.5

 

826

30.7

 

1774

18.3

 

High blood pressure ( 130/85 mm Hg or treatment)

2581

36.8

 

1755

65.2

 

4336

44.7

 

Impaired fasting glucose ( 100 mg/dl or treatment)

1611

23

 

1142

42.4

 

2753

28.4

 

Low HDL (< 50 F/40 M mg/dl or treatment)

1125

16

 

631

23.4

 

1756

18.1

 

Metabolic syndrome

1473

21

 

1153

42.8

 

2626

27.1

 

GFR stages

 Normal or increased GFR (> 90 ml/min/1.73 m2)

5049

72

 

1810

67.2

 

6859

70.7

 

 Mild reduction in GFR (60–89 ml/min/1.73 m2)

1864

26.6

 

823

30.6

 

2687

27.7

 

 Moderate reduction in GFR (45–59 ml/min/1.73 m2)—A

79

1.1

 

48

1.8

 

127

1.3

 

 Moderate reduction in GFR (30–44 ml/min/1.73 m2)—B

14

0.2

 

10

0.4

 

24

0.2

 

 Severe reduction in GFR (15–29 ml/min/1.73 m2)

4

0.1

 

1

0

 

5

0.1

 

 Kidney failure (GFR < 15 ml/min/1.73 m2 or dialysis)

2

0

 

0

0

 

2

0

 
  1. Abbreviations: FMI fat mass index, FFMI fat-free mass index, VAT visceral adipose tissue, SAT subcutaneous adipose tissue